Modeling Arrhythmias Using hPSC-Derived Cardiomyocytes and Tracking Their Excitability
Register Now
STEMCELL Technologies Inc.
Vincenzo Macri, PhD, is a Senior Scientist at STEMCELL Technologies, developing products to support cardiomyocyte stem cell research. Dr. Macri completed his PhD in Physiology from the University of British Columbia. He then worked as a Postdoctoral Research Fellow at the Massachusetts General Hospital and Harvard Medical School. His areas of study included human genetics, cardiac arrhythmias, cellular electrophysiology and cardiomyocyte stem cell biology.
Axion BioSystems
Stacie Chvatal, PhD, is a Senior Application Scientist at Axion BioSystems and plays a leading role in developing Axion’s CiPA Analysis Tool to streamline MEA cardiac analysis. Dr. Chvatal completed her PhD in Biomedical Engineering from the Georgia Institute of Technology and Emory University. She then continued her research as a Postdoctoral Fellow at Georgia Tech. Her research was in neural control movement in healthy and impaired nervous systems of humans and animals.
Wednesday, August 2nd, 2017 - 10 AM PDT | 1 PM EDT | 6 PM BST
If you are unable to attend the live webinar, please register and we will send you a link to view the recording when it becomes available.
Topics
- Overview of the generation of cardiomyocytes from hPSCs
- In vitro modeling of cardiac arrhythmias using cardiomyocytes generated from genetically engineered and patient-derived hPSCs
- Microelectrode array technology to assess the electrophysiological properties of hPSC-derived cardiomyocytes